Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gibbs

Showing results (101-110 of 498) with videos related to

Pageof 50
Sort By:
Heart (British Cardiac Society)|April 16, 1998
The clinical value of ambulatory blood pressure monitoringC R Gibbs, S Murray, D G Beevers
Thorax|December 1, 1983
Biological markers in human lung carcinoma: an immunopathological study of six antigensH R Harach, M Skinner, A R Gibbs
The Journal of Pathology|December 1, 1991
Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomasF G Mayall, B Jasani, A R Gibbs
Diving and Hyperbaric Medicine|July 3, 2014
Vinegar and Chironex fleckeri stingsClinton R Gibbs, Michael Corkeron, Denise F Blake
BMJ (Clinical Research Ed.)|February 5, 2000
ABC of heart failure. Non-drug managementC R Gibbs, G Jackson, G Y Lip
Histopathology|April 1, 1993
The frequency of p53 immunostaining in asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomasF G Mayall, H Goddard, A R Gibbs
Histopathology|September 1, 1996
Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesotheliomaR L Attanoos, H Goddard, A R Gibbs
Histopathology|August 28, 2003
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2R L Attanoos, A Griffin, A R Gibbs
The Journal of Pathology|December 1, 1992
p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sectionsF G Mayall, H Goddard, A R Gibbs
Histopathology|January 1, 1992
An assessment of involucrin as a diagnostically useful immunohistochemical marker in lung tumoursF G Mayall, H Goddard, A R Gibbs
Pageof 50

Showing results (101-110 of 498) with videos related to

Sort By:
Pageof 50
Heart (British Cardiac Society)|April 16, 1998
The clinical value of ambulatory blood pressure monitoringC R Gibbs, S Murray, D G Beevers
Thorax|December 1, 1983
Biological markers in human lung carcinoma: an immunopathological study of six antigensH R Harach, M Skinner, A R Gibbs
The Journal of Pathology|December 1, 1991
Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomasF G Mayall, B Jasani, A R Gibbs
Diving and Hyperbaric Medicine|July 3, 2014
Vinegar and Chironex fleckeri stingsClinton R Gibbs, Michael Corkeron, Denise F Blake
BMJ (Clinical Research Ed.)|February 5, 2000
ABC of heart failure. Non-drug managementC R Gibbs, G Jackson, G Y Lip
Histopathology|April 1, 1993
The frequency of p53 immunostaining in asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomasF G Mayall, H Goddard, A R Gibbs
Histopathology|September 1, 1996
Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesotheliomaR L Attanoos, H Goddard, A R Gibbs
Histopathology|August 28, 2003
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2R L Attanoos, A Griffin, A R Gibbs
The Journal of Pathology|December 1, 1992
p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sectionsF G Mayall, H Goddard, A R Gibbs
Histopathology|January 1, 1992
An assessment of involucrin as a diagnostically useful immunohistochemical marker in lung tumoursF G Mayall, H Goddard, A R Gibbs
Pageof 50